Iright
BRAND / VENDOR: Biolegend

Biolegend, 340302, Purified anti-human CD307e (FcRL5) Antibody, 100μg

CATALOG NUMBER: 340302
Precio habitual$0.99
/
Los gastos de envío se calculan en la pantalla de pagos.
  • In stock, ready to ship

  • Pedido pendiente, envío pronto

Este sitio está protegido por hCaptcha y se aplican la Política de privacidad de hCaptcha y los Términos del servicio.

Product Description

FcRL5, also known as CD307e, CD307, IRTA2, FcRH5, and BXMAS1, is a 106 kD type I transmembrane glycoprotein composed of six-eight extracellular Ig like C2 domains and two cytoplasmic ITIM motifs. The FcRL5 gene is located on chromosome 1q21 and is normally expressed by tonsillar plasma cells and germinal center B cells. It has been suggested that FcRL5 contributes to B cell maturation and B cell receptor modulation. The identification of FcRL5 on a number of transformed cell types including hairy cell leukemia, mantle cell lymphoma, chronic lymphocytic lymphoma, and Burkitt’s lymphoma has prompted interest in it as a potential biomarker or target for immunotherapy. FcRL5 binds all aggregated IgG isotypes.
100μg
Verified Reactivity: Human
Antibody Type: Monoclonal
Host Species: Mouse
Immunogen: P815 cells transfected with FcRL5
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography.
Concentration: 0.5 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C.
Application: FC - Quality tested IP - Reported in the literature, not verified in house
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.125 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Application Notes: Additional reported applications (for the relevant formats) include: immunoprecipitation and blocking1. mAb 509f6 is able to block the binding of FcRL5 to all aggregated IgG isotypes.1
Application References(PubMed link indicates BioLegend citation): Wilson TJ, et al. 2012. J. Immunol. 188:4741. (Block)
Product Citations: McCarthy EE, et al. 2022. Cell Rep. 39:110815. PubMed Obeng-Adjei N, et al. 2017. PLoS Pathog. 13:e1006576. PubMed
RRID: AB_2104586 (BioLegend Cat. No. 340302)
Structure: 106 kD, Fc receptor like, type 1 transmembrane protein, 6-8 Ig like C2 domains, 2 cytoplasmic ITIM motifs.
Distribution: Germinal center B cells, tonsillar plasma cells.
Ligand/Receptor: Aggregated IgG
Cell Type: B cells, Plasma cells
Biology Area: Immunology
Molecular Family: CD Molecules
Antigen References: 1. Davis R, et al. 2007. Annu. Rev. Immunol. 207:528. 2. Mohan J, et al. 2006. Blood 107:4433. 3. Ise T, et al. 2007. Leukemia. 21:169.
Gene ID: 83416
UniProt: View information about CD307e on UniProt.org
Clone: 509f6
Regulatory Status: RUO
Other Names: CD307, IRTA2, FcRH5, IFGP5, BXMAS1
Isotype: Mouse IgG2a, κ


Order Guidelines

1. Price & Stock Available on Request. 📧Click to send email to: service@iright.com

2. Please DO NOT make payment before confirmation.

3. Minimum order value of $1,000 USD required.

Collaboration

Tony Tang

📧Email: Tony.Tang@iright.com

📱Mobile/WhatsApp/Wechat: +86-17717886924